首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1395653篇
  免费   109802篇
  国内免费   10365篇
耳鼻咽喉   19828篇
儿科学   46373篇
妇产科学   37173篇
基础医学   194813篇
口腔科学   35869篇
临床医学   125045篇
内科学   273437篇
皮肤病学   29421篇
神经病学   106274篇
特种医学   55683篇
外国民族医学   745篇
外科学   210467篇
综合类   48878篇
一般理论   388篇
预防医学   103973篇
眼科学   31449篇
药学   107074篇
  77篇
中国医学   9489篇
肿瘤学   79364篇
  2021年   11410篇
  2019年   14315篇
  2018年   16143篇
  2017年   13408篇
  2016年   13734篇
  2015年   17265篇
  2014年   23509篇
  2013年   31706篇
  2012年   44057篇
  2011年   46962篇
  2010年   28528篇
  2009年   26297篇
  2008年   42442篇
  2007年   44978篇
  2006年   45089篇
  2005年   44139篇
  2004年   41230篇
  2003年   39741篇
  2002年   38610篇
  2001年   66383篇
  2000年   68941篇
  1999年   58890篇
  1998年   16264篇
  1997年   14921篇
  1996年   14895篇
  1995年   14821篇
  1994年   13971篇
  1993年   12498篇
  1992年   45432篇
  1991年   44175篇
  1990年   42821篇
  1989年   40660篇
  1988年   37358篇
  1987年   36640篇
  1986年   33949篇
  1985年   32532篇
  1984年   24242篇
  1983年   20313篇
  1982年   11733篇
  1981年   10698篇
  1979年   21350篇
  1978年   14782篇
  1977年   12481篇
  1976年   11636篇
  1975年   12575篇
  1974年   14619篇
  1973年   14076篇
  1972年   12925篇
  1971年   11701篇
  1970年   11030篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs.  相似文献   
3.
4.
5.
6.
7.
8.

Background

Advanced low-grade ovarian carcinoma (LGOC) is difficult to treat. In several studies, high estrogen receptor (ER) protein expression was observed in patients with LGOC, which suggests that antihormonal therapy (AHT) is a treatment option. However, only a subgroup of patients respond to AHT, and this response cannot be adequately predicted by currently used immunohistochemistry (IHC). A possible explanation is that IHC only takes the ligand, but not the activity, of the whole signal transduction pathway (STP) into account. Therefore, in this study, the authors assessed whether functional STP activity can be an alternative tool to predict response to AHT in LGOC.

Methods

Tumor tissue samples were obtained from patients with primary or recurrent LGOC who subsequently received AHT. Histoscores of ER and progesterone receptor (PR) were determined. In addition, STP activity of the ER STP and of six other STPs known to play a role in ovarian cancer was assessed and compared with the STP activity of healthy postmenopausal fallopian tube epithelium.

Results

Patients who had normal ER STP activity had a progression-free survival (PFS) of 16.1 months. This was significantly shorter in patients who had low and very high ER STP activity, with a median PFS of 6.0 and 2.1 months, respectively (p < .001). Unlike ER histoscores, PR histoscores were strongly correlated to the ER STP activity and thus to PFS.

Conclusions

Aberrant low and very high functional ER STP activity and low PR histoscores in patients with LGOC indicate decreased response to AHT. ER IHC is not representative of functional ER STP activity and is not related to PFS.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号